1 month
+0.6%
price return
Year to date
+79.1%
price return
Recent earnings
4/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
36 articles, 7 days
1 month
+0.6%
price return
Year to date
+79.1%
price return
Recent earnings
4/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
36 articles, 7 days
Analysts
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsWhat it reported, what was expected, and what comes next.
Reported Aug 4, 2026
Earnings per share
$0.42 expected
Revenue
No comparable estimate
Company adjusted EPS
From the company's release
The company and the analyst consensus count earnings differently, so the two figures differ. The comparison above uses the analyst basis.
Q3 2026 guidance
$540.0M to $560.0M
No comparable estimate
Next report
EPS expected
$1.18 to $1.21
Revenue expected
18 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
From the release
The three statements, quarter by quarter.
Sep 2025 to Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| RevenueTotal revenue | $230.6M | $270.6M | $308.4M | $392.4M |
| Cost of what it soldCost of revenue | $54.8M | $66.1M | $73.2M | $104.8M |
| Gross profit | $175.8M | $204.5M | $235.1M | $287.6M |
| What it spent | ||||
| Research and development | $78.9M | $93.8M | $125.6M | $135.9M |
| Sales and adminSelling, general and administrative | $22.1M | $23.6M | $25.8M | $36.0M |
| Other operating costsOperating costs not itemised in the filing's summary | $19.4M | $20.1M | $21.9M | $26.4M |
| Total operating expenses | $120.4M | $137.5M | $173.3M | $198.3M |
| What was left | ||||
| Operating profitOperating income | $55.4M | $67.0M | $61.8M | $89.2M |
| Profit before tax | $66.9M | $78.9M | $73.4M | $102.8M |
| TaxIncome tax expense | -$24.3M | $33.9M | -$6.9M | -$50.3M |
| Net profitNet income | $91.1M | $45.0M | $80.3M | $153.1M |
| EBITDAEarnings before interest, tax, depreciation, amortisation | $68.4M | $81.8M | $77.1M | $106.8M |
Business quality, value, and expectations at a glance.
Fundamentals
Richly priced and profitable.
Valuation
Quality
Growth
Filed positions and reported activity tied to this stock.
8 funds hold a position, insiders have been net selling, and 5 market voices are discussing it.
Real smart money
Insiders
Influencers
Yiannis ZourmpanosBullish
Aug 5 · 2x · Says Scorpio product line makes ALAB a cleaner play on AI connectivity, with record Q2 revenue and strong Q3 guidance.
RT by @JonahLuptonBullish
Aug 4 · Reports earnings call takeaways: Scorpio X inflecting early, becoming largest product family, and dollar content per chip rising.
Trend, range, and the price levels that matter.
Technicals
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
$321.6120D support
20D resistance
Returns
Price vs moving averages
Volume pace
Recent coverage and its overall tone.
News
Coverage is bullish
26 bullish · 10 neutral · 0 bearish
Tone of tracked coverage
7,574 Shares in Astera Labs, Inc. $ALAB Bought by Assenagon Asset Management S.A.
Leans bullishAug 13Astera Labs, Inc. (NASDAQ:ALAB) Given Average Recommendation of "Moderate Buy" by Analysts
Leans bullishAug 13Astera Labs Inc Stock (ALAB) Moved Up by 6.11% on Aug 12: Key Drivers Unveiled
BullishAug 12Astera Labs (NASDAQ:ALAB) Shares Gap Up - Should You Buy?
BullishAug 12ALAB Benefits From PCIe Demand: Can It Stay Ahead of Its Competitors?
BullishAug 12Astera Labs Posted 104% Revenue Growth in Q2. Why Is ALAB Down From Its Highs?
Leans bullishAug 11Astera Labs Inc (Derivatives): Latest News, Social Media Updates and Insights
NeutralAug 11Astera Labs, Inc. (ALAB) Stock Price, News, Quote & History
NeutralAug 11JonahLuptonBullish
Aug 4 · Says Q2 revenue beat and Q3 guidance imply 140%+ YoY growth, expects another beat.